A genetics diagnostics company
offering genetics testing to
a global clinical community


Blueprint Genetics provides comprehensive genetics testing for all medical specialties. Blueprints innovative technologies in human rare diseases enable improved tests with higher quality, lower cost and faster lead time. We offer full transparency to our technology, quality and performance, and analytic validations of our technologies.

Our expert team of geneticists and clinicians together with our AI powered CLINT technology provide top quality clinical interpretation and reports, changing the standards of molecular diagnostics. We are accredited by ISO 15189 and CAP (#9257331), and certified by CLIA (#99D2092375).

Inventure joined Blueprint Genetics in 2014.


.@QuestDX will acquire @Bpgenetics, writes @biotechvisigoth

I am very excited about the addition of @BpGenetics to the @QuestDX family.

Big news for Finnish #biotech. Good luck @BpGenetics and @QuestDX on your future journey together!